QSI
Quantum-Si incorporatedNASDAQHealthcare$0.75+0.03%ClosedMarket Cap: $146.9M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.65
P/S
58.79
EV/EBITDA
-1.21
DCF Value
$0.10
FCF Yield
-67.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-135.5%
Operating Margin
-4766.0%
Net Margin
-4160.1%
ROE
-43.9%
ROA
-41.3%
ROIC
-51.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $451.0K | $-17.6M | $-0.08 |
| FY 2025 | $2.4M | $-101.3M | $-0.51 |
| Q3 2025 | $552.0K | $-35.7M | $-0.17 |
| Q2 2025 | $591.0K | $-28.8M | $-0.16 |
Analyst Ratings
View AllCanaccord GenuityHold
2026-03-05Canaccord GenuityHold
2025-12-22Canaccord GenuityHold
2025-10-27Canaccord GenuityHold
2025-09-09HC Wainwright & Co.Buy
2025-05-19Trading Activity
Insider Trades
View AllKeyes Jeffry R.officer: Chief Financial Officer
SellTue Mar 24
Keyes Jeffry R.officer: Chief Financial Officer
SellTue Mar 24
LaPointe Christianofficer: GC & Corp. Secretary
SellTue Mar 24
LaPointe Christianofficer: GC & Corp. Secretary
SellTue Mar 24
Vieceli John S.officer: Chief Product Officer
SellTue Mar 24
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
3.09
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.